期刊文献+

螺内酯对2型糖尿病大鼠血管PAI-1 mRNA表达的影响

Influence of Spironolactone on the Expression of PAI-1 mRNA in Aorta of Rats with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 [目的]4g讨非选择性醛固酮(aldsterone,ALD)受体拮抗剂-螺内酯(spironolactone,SPI)对2型糖尿病(type2diabeticmellitus,T2DM)大鼠血管纤溶酶原激活物抑制剂-1(plasminogenactivatorinhibitor-1,PAI-1)tuRNA的表达的影响。【方法】高脂高糖喂养加小剂量链脲佐菌素(streptozotocin,STz)腹腔注射法建立2型糖尿病大鼠模型,将成膜的T2DM大鼠随机分为糖尿病对照组(DM—C组)和SPI干预组(DM_S组),继续高脂高糖喂养,正常对照组(NC组)大鼠继续给予普通饲料喂养,其中DM—s组每天给予SPI40rag/(kg·d)灌胃,NC纽和DM—c组每天等量蒸馏水灌胃。每2周监测大鼠体重和血糖水平,第16周末处死大鼠,收集血液标本,检测空腹血糖(FBG)、糖化血红蛋白(HbAlC%)、甘油三酯(TG)、胆固醇(TG)、血钾(K’)。用RT—PCR法检测各组大鼠胸主动脉PAI-1mRNA表达。【结果】DM-C组和DM_S组大鼠FBG、HbAlC%、TG均显著高于NC组(P〈0.01),而DM—s组和DM—C组比较差异无统计学意义(P〉0.05);三组之间的血K’水平比较差异无统计学意义(P〉0.05);DM—C组和DM—S组大鼠胸主动脉PAI-1mRNA的表达显著高于NC组(P〈0.01),且DM—C组高于DM—s组(P〈0.05)。【结论1SPI能通过下调T2DM大鼠主动脉PAI-1rnRNA的表达而发挥血管保护作用。 [Objective]To explore the influence of nonselective aldosterone(ALD) receptor antagonist-spirono lactone(SPI) on the expression of type-1 plasminogen activator inhibitor(PAI-1) mRNA in rats with type 2 diabe- tes mellitus(T2DM). [Methods] The model of T2DM rats was established by being fed with high-sucrose-high-fat diet and intraperitoneally injected with low dose streptozotocin(STZ). Rat models of T2DM were randomly divided into diabetes mellitus control group(group DM-C) and SPI intervention group(group DM-S). Each rat in group DM-C and DM-S was continuously fed with high-sucrose-high-fat diet. Rats in normal control group(group NC) were fed with routine animal feeds. Group DM-S was treated with SPI 40mg/kg. day via intragastric administra- tion, while group DM-C and NC were treated with corresponding distilled water. Body weight and blood glucose were monitored every two weeks. Rats were sacrificed at the end of 16 weeks, and blood samples were collected. The fasting blood glucose (FBG), glycosylated hemoglobin A1 c ( HbAI c~ ), triglyeeride (TG), total cholesterol (TC) and blood potassium(K+ ) were measured. RT-PCR was used to determine PAI 1 in aorta of rats in each group. [Results] FBG, HbAlc~ and TG in group DM-C and group DM-S were markedly higher than those in group NC( P 〈0.01), but there was no different between group DM-S and DM-C( P〉0.05). There was no sig nificant difference in blood K+ among three groups( P 〉0.05). The expression of PAI-1 mRNA in group DM-C and DM-S was significantly higher than that in group NC( P〈0.01), and that in group DM-C was higher than that in group DM-S( P %0.05). [Conclusion]SPI may play the protective role for vascular endothelium in T2DM rats through down regulating the expression of PAI-1 mRNA.
出处 《医学临床研究》 CAS 2013年第1期38-40,共3页 Journal of Clinical Research
关键词 糖尿病 2型 遗传学 螺内酯 药理学 纤溶酶原激活物抑制物1 RNA 信使 大鼠 diabetes mellitus, Type 2/GE spironolactone/PD plasminogen activator inhibitor 1 RNA,messenger rats
  • 相关文献

参考文献8

  • 1Mantero F,Lucarelli G. Aldosterone antagonists in hypertension and heart failure[J].Annales d'Endocrinologie,2000,(01):53-60.
  • 2Eva A,Marcus L,Tom O. UPA and PAI-1 in rectal cancer;relationship to radiotherapy and clinical outcome[J].Journal of Surgical Research,2009,(01):46-53.
  • 3Velusamy T,Jain SK. Effects of high glucose and ketosis(acetoacetate β-hydroxybutyrate) on PAI-1 secretion in human umbilical vascular endothelial cells[J].Clinical and Applied Thrombosis/Hemostasis,2011,(07):288-292.
  • 4Venugopal J,Hanashioro K,Nagamine Y,Nagamine Y. Kegulation of PAI-1 gene expression during adipogenesis[J].Journal of Cellular Biochemistry,2007,(02):369-380.
  • 5Kitagawa N,Yano Y,Gabazza EC. Different metabolic correlations of thromibin activitable fibrinolysis inhibitor-1 in non-obese type 2 diabetic patients[J].Dibetes Res Clin Pract,2006,(02):150-157.
  • 6Laima B,Kevin,Alicia J. Plasminogen activator inhibitor-1 actvity in type 2 diabetic:a different relaticonship with coronary heart disease and diabetic retinopathy[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2008,(04):786-791.
  • 7李晓东,丁新国,张红梅,高山林,李英.醛固酮对肾小球系膜细胞纤溶酶原激活物抑制物1基因表达的影响[J].细胞与分子免疫学杂志,2008,24(1):87-88. 被引量:1
  • 8Huang W,Xu C,Kahng KW. Aldosterone and TGF-beta1 synergistically increase PAI-1and decrease matrix degradation in rat renal mesangial and fibroblast cells[J].American Journal of Physiology-Renal Physiology,2008,(06):1287-1295.

二级参考文献7

  • 1李晓东,陈孝文,唐德燊,梁东,刘华锋.醛固酮对肾小球系膜细胞合成分泌纤维连接蛋白和TGF-β1表达的影响[J].细胞与分子免疫学杂志,2007,23(2):140-142. 被引量:4
  • 2Ibrahim HN, Hostetter TH. Aldosterone in renal disease [J].Curr Opin Nephrol Hypertens. 2003. 12 ( 2 ) : 159 - 164.
  • 3Krag S, Danielsen CC, Carmeliel P, et al. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease[J].Kidney Int. 2005, 68(6) : 2651 -2666.
  • 4Harper PA, Robinson JM, Hoover RL, et al. Improved methods for culturig rat glomerular cells[J].Kidney Int, 1984, 26 ( 6 ) : 875 - 880.
  • 5Schnaper HW,Kopp JB.Renal fibrosis[J].Front Biosci,2003,8(1):68-86.
  • 6Baricos WH,Reed JC,Cortez SJ.Extracellular matrix degradation by cultured mesangial cells:mediators and modulators[J].Exp Biol Med,2003,228(9):1018-1022.
  • 7Fujisawa G,Okada K,Muto S,et al.Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats[J].Kidney Int ,2004,66(4):1493-1502.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部